AHAfton L. Hassett

Afton L. Hassett

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Afton L. Hassett has a total of 260 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Engagement With a Relaxation-Based Mobile Health Intervention for Perioperative Anxiety: Prospective Longitudinal Cohort Mixed Methods Study

    by Xinghui Yan, Afton L Hassett, Jennifer F Waljee, Mark W Newman, Sun Young Park, Rongqi Bei, Noelle E Carlozzi

    Background: Relaxation-based mobile health (mHealth) interventions hold strong potential to address perioperative anxiety and pain management in a scalable manner. However, there is limited research on how surgical patients engage with these interventions and what aspects may be most helpful. Objective: This study had 3 goals: (1) explore how users interact with a relaxation-based mHealth intervention during the perioperative period; (2) understand how user performance and perceptions relate to perceived benefits; and (3) identify design considerations to enhance user engagement and behavior change outcomes in mHealth interventions. Methods: We conducted a prospective longitudinal cohort, mixed methods study to evaluate user engagement with MiCarePath, a relaxation-based mHealth intervention. A total of 19 perioperative patients (mean age 41.3 years; 14/19, 74%, female) undergoing elective surgery and reporting sometimes-to-always anxiety were enrolled using 3 recruitment methods. Participants used the app from 10 days before surgery to 4 weeks after surgery. We collected quantitative data on video engagement metrics (eg, duration of watching, response rate to video prompts) and ecological momentary assessments of anxiety and pain. Concurrently, we conducted semistructured, data-prompted interviews at 3 time points to assess user perceptions. These data were integrated using descriptive statistics, repeated-measures ANOVA, and qualitative thematic analysis to examine the relationship between user performance and perceived benefits. Results: Eleven participants reported developing or improving relaxation-based self-management strategies (high benefit), whereas 8 reported little benefit from the intervention. The high-benefit group showed significantly greater total watching time (difference 223.8 minutes, 95% CI 95.54-366.46 minutes, P<.001), higher adherence to video prompts (73.45% vs 34.60%, P<.001), and greater perceived helpfulness of the content (79.80% vs 25.50%, P<.001) compared with the low-benefit group. A significant group-by-time interaction effect was observed for engagement (F1,17=17.02, P<.001). No difference was observed in delay in response to video prompts. However, within each group, participant perceptions were not fully reflected in performance. Some participants in the high-benefit group showed decreased video watching after surgery but still reported feeling engaged with the intervention. Interview data revealed that “intentional use” behavior—where users actively seek content to manage symptoms independent of prompts—distinguished these participants. Those who developed intentional use were able to practice relaxation techniques without the app and resume app engagement following contextual disruptions. Conclusions: This study explored user engagement with a relaxation-based mHealth intervention for perioperative care, advancing the literature by integrating user perceptions and performance for digital anxiety and pain management. Results indicate that perceived benefit may not always be reflected in user performance. Intentional use emerges as a promising indicator of effective mHealth engagement in perioperative care. Future designs should aim to foster intentional use through features such as reflection prompts and adaptive notifications. Future work should also develop computational models to detect intentional use and evaluate adaptive interventions in larger cohorts.

  • Open Access

    Randomized controlled trial of medical assistant-coached behavioral intervention for chronic pain

    by Afton L Hassett, Terri Voepel-Lewis, Guohao Zhu, Acacia Parks, Alexander Tsodikov, Joseph Long, Sana Shaikh, Beth Burgess, Chad M Brummett, Daniel J Clauw, et al.

    Background Chronic spinal pain with widespread symptoms often responds poorly to peripherally focused treatments. Cognitive-behavioral therapy (CBT) can help but typically yields modest effects. This trial evaluated whether adding resilience-enhancing activities to medical assistant-coached CBT (PRISM-CBT) improves outcomes. Methods Adults with spinal pain and fibromyalgia symptoms were randomized to PRISM-CBT (n=119), standard CBT (n=120), or usual care (UC; n=60). The primary outcome was the Fibromyalgia Impact Questionnaire-Revised (FIQR) global impact score at 8 weeks (0–100; higher=worse). Secondary outcomes were pain interference and pain severity measured with the Brief Pain Inventory (BPI) (0–10; higher=worse). Results The primary outcome showed no difference between PRISM-CBT and usual care at 8 weeks, with an adjusted between-group difference of 0.20 points (95% CI –4.81 to 5.20, p=0.939). Yet, by 12 months, PRISM-CBT demonstrated a 7.4-point greater improvement compared with usual care (95% CI 0.15 to 14.64, p=0.045) and a 4.8-point greater improvement versus CBT at 8 weeks (95% CI 0.00 to 9.57, p=0.050). PRISM-CBT produced the most consistent benefit in BPI pain interference. Compared with usual care, interference was lower by 0.88 points at both 8 weeks (95% CI 0.25 to 1.50, p=0.006) and 6 months (95% CI 0.23 to 1.54, p=0.009) and by 1.42 points at 12 months (95% CI 0.53 to 2.32, p=0.002). Compared with standard CBT, interference was lower at 8 weeks (0.98 points, 95% CI 0.38 to 1.57, p=0.001), 6 months (0.63 points, 95% CI 0.01 to 1.25, p=0.045), and 12 months (1.92 points, 95% CI 1.09 to 2.76, pConclusions This scalable, medical assistant-coached digital program shows promising benefits, including greater reductions in pain interference and a long-term improvement in global symptom burden, despite no difference at the primary endpoint.

  • Introduction to the Special Theme Issue: Pain Science and Therapy in Rheumatic Disease

    by Afton L. Hassett, S. Sam Lim, Kelli D. Allen

  • Open Access

    Considerations for Issues of Regression to the Mean and Contextual Effects in Clinical Trials for Pain in Rheumatic Diseases

    by Yen T. Chen, Guohao Zhu, Afton L. Hassett, Daniel Clauw, Susan L. Murphy

    Recently, there has been growing discussion about how to best assess pain in clinical trials in rheumatic diseases. Reliable measurement of pain outcomes is essential for accurately determining the effectiveness of treatments. Although pain intensity is the most common measure of change in pain trials, other pain‐related measures, such as pain interference, are also frequently assessed. Interpreting treatment effects on these outcomes can be complicated due to statistical phenomena, particularly regression to the mean and contextual effects. These issues can substantially distort clinical trial findings, potentially leading to inaccurate conclusions about the efficacy of interventions. The present article provides an overview of regression to the mean and contextual effects, emphasizing their implications for internal validity, clinical decision‐making, and ethical considerations in trials. Additionally, this article highlights key study design and analysis considerations, including methodologic and statistical approaches, that researchers can implement to mitigate or better account for these challenges. Practical recommendations are offered to enhance the rigor of pain assessment, with specific attention to osteoarthritis as a representative example within rheumatic disease research. By recognizing and addressing regression to the mean and contextual effects proactively, researchers can strengthen trial outcomes, improve clinical interpretations, and support the identification of effective treatments.


  • Open Access

    Baseline characteristics of participants in the Biomarkers for Evaluating Spine Treatments clinical trial: a sequential multiple assignment randomized trial for chronic low back pain

    by Bryce Rowland, Kelly S Barth, Kevin M Bell, Amber K Brooks, Andrea L Chadwick, Annika Cleven, Robert W Hurley, Sean Mackey, Kushang V Patel, Sara R Piva, et al.

    Objective: Chronic low back pain (cLBP) is a significant public health problem in the United States. A method to identify treatments that are most likely effective for an individual patient based on their unique characteristics is needed. Methods: The Biomarkers for Evaluating Spine Treatments (BEST) Trial is a sequential, multiple assignment, randomized trial designed to estimate an optimal treatment or combination of treatments to reduce pain intensity and interference at 24 weeks in individuals with cLBP. Results: We describe the patient-reported characteristics of the BEST Trial at the Baseline visit. Data collection for extensive required phenotyping is reported. We analyzed the run-in period of the BEST Trial to evaluate predictors of run-in failure. The BEST Trial enrolled 1019 participants and randomized 805 participants (61.6% female, mean age 50.4, 12.5% Black or African American) to the first stage of treatment. We collected extensive required phenotyping on all 805 randomized BEST Trial participants, and additional optional phenotyping on 510 (63.4%) participants. Conclusions: The BEST Trial successfully enrolled a racially and geographically diverse sample of chronic low back pain patients and completed rich phenotypic assessments to inform our primary goal of identifying in whom different treatments show optimal response. We demonstrated the feasibility of collecting extensive phenotypic assessments in a multi-site clinical trial of cLBP. Clinical trial registration number: The Biomarkers for Evaluating Spine Treatments (BEST) Trial is registered on ClinicalTrials.gov. Registration number: NCT05396014 (https://clinicaltrials.gov/study/NCT05396014).


  • Open Access

    The design and rationale of the Biomarkers for Evaluating Spine Treatments trial: a sequential multiple assignment randomized trial

    by Matthew C Mauck, Kelly S Barth, Kevin M Bell, Amber K Brooks, Andrea L Chadwick, Cameron A Gunn, Robert W Hurley, Anastasia Ivanova, Sara R Piva, Michael J Schneider, et al.

    Objective: Chronic low back pain (cLBP) is a common condition that impacts quality of life and function. There are many evidence-based treatments to address cLBP; however, treatment effects are modest, perhaps in part due to individual variation in treatment response. The Biomarkers for Evaluating Spine Treatments (BEST) trial was designed as the collaborative centerpiece of the Back Pain Consortium (BACPAC) research program. This consortium was sponsored by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) as part of the Helping to End Addiction Long-term (HEAL) Initiative. Design: The BEST trial was a sequential multiple assignment randomized trial (SMART) designed with the primary goal of identifying in whom different treatments show optimal response. The primary focus of the study was to use patient features, including biomarkers and phenotypic measures, to identify subsets of persons with cLBP who respond best to specific common treatments. Methods: Four interventions were chosen for the trial: Enhanced Self-Care, Acceptance and Commitment Therapy, Duloxetine, and Evidence-Based Exercise and Manual Therapy. Following a run-in period and baseline assessment, participants were randomized to 1 of the 4 treatments for the first 12-week intervention period. Participants were reassessed and based on their self-reported response to initial treatment, continued that initial treatment, were augmented with an additional randomly assigned treatment, or were switched to a new treatment. Conclusion: This trial was designed to deliver rich phenotypic data that will both potentially aid in the discovery of phenotypic characteristics that predict treatment response and provide a greater mechanistic understanding of cLBP. Clinical trial registration number: The Biomarkers for Evaluating Spine Treatments (BEST) trial is registered on ClinicalTrials.gov (Registration number: NCT05396014; https://clinicaltrials.gov/study/NCT05396014).


  • Open Access

    At-Home Morning Bright Light Treatment for Chronic Nociplastic Pain: Protocol for a Randomized Clinical Trial (Preprint)

    by Helen J Burgess, Allie A Rodgers, Kiley A McNeil, Jackson Mott, Agnes Fejer, Tori Dereski, Muneer Rizvydeen, Kimberly T Sibille, Hyungjin Myra Kim, Cherie Cofield, et al.

    BACKGROUND Fibromyalgia, the quintessential nociplastic pain condition, affects more than 20 million Americans and results in significant disability, lost productivity, and poor quality of life, with profound individual and societal cost. As pharmacological treatment approaches offer only modest benefits and result in a high rate of discontinuation due to adverse effects, nonpharmacological interventions such as physical therapy, exercise, and cognitive behavioral therapy are recommended. However, cost and access to these treatments can create barriers to care, and engagement can be problematic. Morning bright light treatment is a promising option for improving fibromyalgia symptoms, with early studies indicating clinically meaningful improvements in fibromyalgia symptoms. OBJECTIVE This study aims to prospectively examine the potential benefits and active elements of morning bright light treatment and sleep timing stabilization for individuals with fibromyalgia in the largest randomized controlled trial to date. METHODS We will recruit 390 adults who meet diagnostic criteria for fibromyalgia and report at least mild symptoms. Participants will be randomized to one of three groups: 4 weeks of morning bright light treatment (1 hour per day, using a commercially available Re-timer device), 4 weeks of sleep timing stabilization alone (a component of morning bright light treatment, some benefit anticipated), or 4 weeks of treatment as usual, with equivalent study contact. Patient-reported outcomes of function and pain will be assessed before and after treatment, with mood, sleep quality, and morningness-eveningness examined as potential mediators of treatment effects. Social determinants of health risk will be examined as a potential moderator influencing baseline symptoms, treatment engagement, and treatment response. RESULTS Data collection began in September 2024 and is projected to end in March 2029. CONCLUSIONS Morning bright light treatment is well-positioned to be an effective nonpharmacological treatment for fibromyalgia with minimal side effects. The study findings will provide important insights relevant to the development of morning bright light treatment as an accessible treatment for chronic nociplastic pain. CLINICALTRIAL ClinicalTrials.gov NCT06567886; https://clinicaltrials.gov/study/NCT06567886 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/75060

  • Open Access

    At Home Morning Bright Light Treatment for Chronic Nociplastic Pain: A Protocol for A Randomized Clinical Trial (Preprint)

    by Helen J. Burgess, Allie A. Rodgers, Kiley A. McNeil, Jackson Mott, Agnes Fejer, Tori Dereski, Muneer Rizvydeen, Kimberly T. Sibille, Hyungjin Myra Kim, Cherie Cofield, et al.

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).


  • Open Access

    Caregiver and Adolescent Perspectives on Giving and Receiving Care After NonEmergency Surgery: A Qualitative Study

    by Sydney E. S. Brown, Camila Costa, Alyssa Kelly, Sarah Oh, Daniel Clauw, Afton Hassett, Noelle E. Carlozzi

    Objectives: Over 1.5 million adolescents undergo surgery each year in the United States. While surgery is performed to improve pain and physical functioning, there may be temporary disability and an increased reliance on caregivers during recovery. Caregivers not accustomed to providing this level of care for adolescents used to greater independence may struggle. We sought to better understand the dyadic experience of at‐home care for adolescent patients after nonemergency surgery. Methods: We conducted semi‐structured interviews with adolescent patients aged between12and 17 years and an associated caregiver, separately, 2 weeks following nonemergency surgery at a tertiary care pediatric hospital. Interviews were analyzed using latent manifest content analysis concurrent with data collection. Recruitment occurred until thematic saturation was reached. Results: Semi‐structured interviews were conducted among 31 adolescent‐caregiver dyads. Sixteen caregivers and 12 adolescents described needing or providing help with activities of daily living (ADLs) and/or instrumental ADLs. Four themes emerged: (1) caregiver feelings of overwhelm, primarily among those helping with ADLs; (2) care activities described as something a “good caregiver” does contrasted with the more neutral way in which adolescents described needing help; (3) discrepancies between caregiver and adolescent perspectives regarding increased family interactions resulting from needing or providing care; and (4) the importance of peer friendships to adolescents throughout surgical recovery. Discussion: Half of the adolescents and caregivers reported providing or requiring significant assistance with basic care needs after surgery. While some caregivers felt overwhelmed, others derived satisfaction from being a “good” caregiver and increased family time; adolescents felt more neutral about these interactions. Connections with friends (in‐person or online) were helpful to adolescents. Results suggest that interventions directed toward improving caregiver support and helping them find positive aspects of caregiving, as well as encouraging adolescent connection with their friends may improve the perceived quality of recovery in this population.